Search results
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo Finance· 2 days agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
Western Multinationals Fleeing Nigeria Are Being Replaced by Asian and Turkish Firms
Bloomberg via Yahoo News· 5 days ago(Bloomberg) -- As US and Europe-based multinationals exit Nigeria, Asian and local companies are...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters· 3 days ago, opens new tab and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
GSK (LON:GSK) Given Underweight Rating at JPMorgan Chase & Co.
ETF DAILY NEWS· 4 days agoJPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. Several other equities ...